HSINCHU, April 25, 2022 /PRNewswire/ — The Edison Prize, one of the world’s most revered innovation awards, announced the 2022 winners on April 21 in Fort Myers, Florida. On this year’s program, I TRY won two awards in the science and medicine category: a silver medal for BioMS-Tia 3D printed bone implant for tissue integration and a bronze for diabetic retinopathy (DR) detection system Portable Edge AI-DR. This is the sixth year that ITRI has won this honor, demonstrating its creativity and consistency in innovating for a better future. Other 2022 winners include leading companies such as 3M, Abbott, Dow and IBM.
“Being an Edison Awards winner is the number one honor for creating a successful and revolutionary new product or service that improves people’s lives. ITRI has far surpassed the rest of our nominees with its continuous work of innovation in many categories,” said Frank Bonafilia, executive director of the Edison Awards. He further commented on the two ITRI winners. The BioMS-Ti solution, he pointed out, uses new 3D-printed materials that mimic real bone, producing an attractive design for judges. Meanwhile, he said the Portable Edge AI DR, which uses artificial intelligence to screen for diabetic retinopathy, is known to be ahead of the game and is wonderful for use by both doctors and non-doctors alike. -doctors.
The COVID-19 pandemic has triggered the rise of digital health technologies and AI-based solutions. ITRI’s two winners at the 2022 Edison Awards clearly demonstrate its keen awareness of market demands and both come from the area of quality healthcare as part of ITRI’s 2030 technology strategy and roadmap, which addresses the latest trends such as regenerative medicine and smart medical technologies.
Dr. Chii-Wann Lin, Vice President and General Manager of Biomedical Technology and Devices Research Laboratories at ITRI, noted that BioMS-Ti can be tailored to each patient and accelerate bone repair, while the design allows for custom designs and a myriad of shapes and sizes such as bone screws, sacral plate, and interbody fusion cages, giving it great flexibility for various applications.
“Portable Edge AI-DR uses an AI-assisted diagnostic system to offer mobile services,” commented Dr. Pang-An Ting, General Manager of Information and Communications Research Laboratories at ITRI. “It can reduce the need for hospital visits for patients and enable early diagnosis to improve preventive health care and public welfare,” he said.
Learn more about ITRI’s winning innovations:
BioMS-Ti is a hybrid bionic skeleton structure made using SLM 3D printing technology. The bioactive cannulated implant has a controllable porous structure design and can be combined with bioceramic or osteogenic materials to accelerate bone regeneration and hard/soft tissue interface integration. The custom design and manufacturing processes give it tremendous potential as custom precision medical implants in orthopedics, dentistry and aesthetic medicine. BioMS-Ti has been licensed to Ingrowth Biotech Co. Ltd. for the design and manufacture of ligament bone nails and to BlueLab Inc. for the production of interbody fusion cages.
Portable Edge AI-DR is an AI-assisted system for detecting diabetic retinopathy (DR). It can locate four major lesions, classify five levels of diabetic retinopathy severity, and can help doctors diagnose DR, providing advanced care for patients with diabetic eye complications in a portable medical device and reducing the need for inconvenient referrals to ophthalmologists for patients with mild conditions. DR. ITRI collaborated with medical device designer and manufacturer Medimaging Integrated Solution Inc. (MiiS) to develop the wearable solution, including the wearable fundus camera and cutting-edge AI computer.
Since 1987, the Edison Awards have honored some of the world’s most innovative new products, services and business leaders, with past winners including renowned companies such as Cisco, Qualcomm, Lockheed Martin and SpaceX. The award recognizes excellence in new product and service development, marketing, human-centered design and innovation, based on the four criteria of concept, value, delivery and impact. To see the full list of 2022 winners, please visit https://edisonawards.com/winners2022.php.
The Industrial Technology Research Institute (ITRI) is one of the world’s leading technology R&D institutions aimed at innovating for a better future for society. Founded in 1973, ITRI has played a pivotal role in transforming Taiwanese industries from labor-intensive to innovation-driven. To respond to market needs and global trends, it launched its 2030 technology strategy and roadmap and focuses on developing innovation in the areas of smart life, quality health and sustainable environment. It also strives to strengthen intelligence enabling technology to support diversified applications.
Over the years, ITRI has been dedicated to incubating startups and spin-offs, including well-known names such as UMC and TSMC. In addition to its headquarters in Taiwan, ITRI has branch offices in the United States, Europe and Japan with the aim of expanding its R&D reach and promoting international cooperation across the world. For more information, please visit https://www.itri.org/eng.
Show original content to download multimedia:https://www.prnewswire.com/news-releases/itri-named-a-double-winner-at-edison-awards-2022-301531754.html
SOURCE Industrial Technology Research Institute